“…9 This increase in diversity seems to reflect an improved selective pressure, requires time to develop, 10 and is seen mostly in patients with virologic and CD4 T-cell responses to HAART. 17,19 With successful immune response, it would be reasonable to predict that enhanced control of HCV would result. As a consequence, a greater recognition of virus-infected hepatocytes and consequent alanine aminotransferase (ALT) flares are expected to occur.…”